Deal of the Day — limited-time pharmacy picks!
Epiget 50 Injection

Epiget 50 Injection

Prescription requiredRx Required

Salt Composition: Epirubicin (50mg)

Expiry Date: 01/2028

Special offer

Buy at $36.00

$36.00

Inclusive of all taxes

▼

1 Inj

About The Product

Blood Cancer

Description

Epiget 50 Injection is an anticancer medication prescribed by the doctor to treat multiple cancers. It mainly treats ovarian cancer, gastric (stomach) cancer, small cell lung cancer, and head and neck cancers.It is also part of Adjuvant Therpay after the surgery of Breast Cancer.

Epiget 50 Injection contains 50mg of Epirubicin that induces self death mechanism in cancer cells.

Common Side Effects

  • Epiget 50 Injection is an anticancer injection.
  • Its salt in reaction with the body leads to numerous side effects like any other medication.
  • Symptoms may vary from mild to severe.
  • If these side effects remain for longer period of time, consult your doctor immediately. ● Hair loss ● Mouth sores ● Nausea ● Weakness ● Low red/white/platelet counts ● Diarrhea ● Fever ● Nail changes ● Fluid retention ● Muscle pain ● Rashes ● Hot flashes ● Gastrointestinal inflammation ● Febrile neutropenia ● Allergic reactions ● Heart damage ● Severe bone marrow suppression

Dosage And Administration

  • Epiget 50 Injection is administered intravenously, either alone or with other cancer treatment therapies, depending on the cancer's type and stage.Patients should not self-administer; it must be injected by a doctor or trained nurse.
  • Consult a doctor for precise dosage and timing.

Mechanism Of Action

Epiget 50 Injection contains 50mg of Epirubicin that inhibits topoisomerase II to prevent DNA unwinding and replication, releasing cytotoxic chemical that damage cancer cells on its own.

Faqs

Epiget 50 Injection is a chemotherapy based injection.

It is used to treat breast cancer, ovarian cancer, gastric (stomach) cancer, small cell lung cancer, and head and neck cancers.

References

• Conte, P. F., Gennari, A., Landucci, E., & Orlandini, C.

(2000). Role of epirubicin in advanced breast cancer.

Clinical breast cancer, 1, S46-S51. • Plosker, G. L., & Faulds, D.

(1993). Epirubicin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Drugs, 45(5), 788-856. • Cersosimo, R. J., & Hong, W.

K. (1986).

Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. Journal of Clinical Oncology, 4(3), 425-439. • Robert, J.

(1994). Clinical pharmacokinetics of epirubicin.

Clinical pharmacokinetics, 26(6), 428-438.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026